CFTR is a tumor suppressor gene in murine and human intestinal cancer-Reference-Cited by-同舟云学术

CFTR is a tumor suppressor gene in murine and human intestinal cancer

Published:2016-01-11 Issue:32 Volume:35 Page:4191-4199
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Than B L N,Linnekamp J F,Starr T K,Largaespada D A,Rod A,Zhang Y,Bruner V,Abrahante J,Schumann A,Luczak T,Niemczyk A,O'Sullivan M G,Medema J P,Fijneman R J A,Meijer G A,Van den Broek E,Hodges C A,Scott P M,Vermeulen L^ORCID,Cormier R T

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2015483.pdf

Reference54 articles.

1. De Lisle RC, Borowitz D . The cystic fibrosis intestine. Cold Spring Harb Perspect Med 2013; 3: a009753.

2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066–1073.

3. Pedersen SF, Stock C . Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential. Cancer Res 2013; 73: 1658–1661.

4. Neglia JP, FitzSimmons SC, Maisonneuve P, Schöni MH, Schöni-Affolter F, Corey M et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995; 332: 494–499.

5. McWilliams R, Highsmith WE, Rabe KG, de Andrade M, Tordsen LA, Holtegaard LM et al. Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma. Gut 2005; 54: 1661–1662.

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased activity of epithelial Cdc42 Rho GTPase and tight junction permeability in the Cftr knockout intestine;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-10-01

2. Evolving data on risk and current screening recommendations for colorectal cancer in cystic fibrosis: Pre‐ and posttransplant;Pediatric Pulmonology;2024-08-06

3. CFTR and colorectal cancer susceptibility: an urgent need for further studies;Trends in Cancer;2024-08

4. Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy;Autoimmunity Reviews;2024-06

5. Predicting weight gain in patients with cystic fibrosis on triple combination modulator;Pediatric Pulmonology;2024-04-12